Literature DB >> 16513285

Ischemic preconditioning as a possible explanation for the age decline relative mortality in sleep apnea.

Lena Lavie1, Peretz Lavie.   

Abstract

Breathing disorders in sleep are prevalent phenomena profoundly affecting the cardiovascular system. Mortality studies of sleep apnea patients revealed maximum risk of dying in younger patients and a pronounced age-decline in relative mortality reaching non significant levels in patients older than 50 years. We hypothesize that the age decline mortality risk in sleep apnea can be explained by cardiovascular and cerebrovascular protection conferred by ischemic preconditioning resulting from the nocturnal cycles of hypoxia-reoxygenation. The association of ischemic preconditioning with increase levels of vascular endothelial growth factor, increased production of oxygen reactive species, heat shock proteins, adenosine, and TNF-alpha, all demonstrated in sleep apnea, provide preliminary support to our hypothesis.

Entities:  

Mesh:

Year:  2006        PMID: 16513285     DOI: 10.1016/j.mehy.2005.10.033

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  30 in total

Review 1.  Sleep-disordered breathing and cognition in older adults.

Authors:  Molly E Zimmerman; Mark S Aloia
Journal:  Curr Neurol Neurosci Rep       Date:  2012-10       Impact factor: 5.081

Review 2.  Obstructive Sleep Apnea and the Brain: a Focus on Gray and White Matter Structure.

Authors:  Andrée-Ann Baril; Marie-Ève Martineau-Dussault; Erlan Sanchez; Claire André; Cynthia Thompson; Julie Legault; Nadia Gosselin
Journal:  Curr Neurol Neurosci Rep       Date:  2021-02-14       Impact factor: 5.081

Review 3.  Emerging co-morbidities of obstructive sleep apnea: cognition, kidney disease, and cancer.

Authors:  Nadia Gildeh; Panagis Drakatos; Sean Higgins; Ivana Rosenzweig; Brian D Kent
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

Review 4.  The Relationship between Obstructive Sleep Apnea and Alzheimer's Disease.

Authors:  Andreia G Andrade; Omonigho M Bubu; Andrew W Varga; Ricardo S Osorio
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

5.  Sleep-disordered breathing and postoperative outcomes after elective surgery: analysis of the nationwide inpatient sample.

Authors:  Babak Mokhlesi; Margaret D Hovda; Benjamin Vekhter; Vineet M Arora; Frances Chung; David O Meltzer
Journal:  Chest       Date:  2013-09       Impact factor: 9.410

6.  Moderate-to-severe obstructive sleep apnea is associated with telomere lengthening.

Authors:  Katarzyna Polonis; Virend K Somers; Christiane Becari; Naima Covassin; Phillip J Schulte; Brooke R Druliner; Ruth A Johnson; Krzysztof Narkiewicz; Lisa A Boardman; Prachi Singh
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-08-19       Impact factor: 4.733

7.  Undiagnosed obstructive sleep apnea is independently associated with reductions in quality of life in middle-aged, but not elderly men of a population cohort.

Authors:  Sarah L Appleton; Andrew Vakulin; R Douglas McEvoy; Andrew Vincent; Sean A Martin; Janet F Grant; Anne W Taylor; Nick A Antic; Peter G Catcheside; Gary A Wittert; Robert J Adams
Journal:  Sleep Breath       Date:  2015-04-21       Impact factor: 2.816

8.  Dichotomous effects of chronic intermittent hypoxia on focal cerebral ischemic injury.

Authors:  Katherine A Jackman; Ping Zhou; Giuseppe Faraco; Pablo M Peixoto; Christal Coleman; Henning U Voss; Virginia Pickel; Giovanni Manfredi; Costantino Iadecola
Journal:  Stroke       Date:  2014-04-08       Impact factor: 7.914

9.  Acute pulmonary embolism in patients with obstructive sleep apnea: frequency, hospital outcomes, and recurrence.

Authors:  Zeynep Idil Seckin; Haytham Helmi; Timothy J Weister; Augustine Lee; Emir Festic
Journal:  J Clin Sleep Med       Date:  2020-07-15       Impact factor: 4.062

Review 10.  Tumor necrosis factor and stroke: role of the blood-brain barrier.

Authors:  Weihong Pan; Abba J Kastin
Journal:  Prog Neurobiol       Date:  2007-08-06       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.